Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Oncogene

Results: 1-25/785

Authors: Cogswell, PC Guttridge, DC Funkhouser, WK Baldwin, AS
Citation: Pc. Cogswell et al., Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3, ONCOGENE, 19(9), 2000, pp. 1123-1131

Authors: Seol, DW Chen, QY Zarnegar, R
Citation: Dw. Seol et al., Transcriptional activation of the Hepatocyte Growth Factor receptor (c-met) gene by its ligand (Hepatocyte Growth Factor) is mediated through AP-1, ONCOGENE, 19(9), 2000, pp. 1132-1137

Authors: Suzuki, J Kaziro, Y Koide, H
Citation: J. Suzuki et al., Positive regulation of skeletal myogenesis by R-Ras, ONCOGENE, 19(9), 2000, pp. 1138-1146

Authors: Reynaud, EG Guillier, M Leibovitch, MP Leibovitch, SA
Citation: Eg. Reynaud et al., Dimerization of the amino terminal domain of p57(Kip2) inhibits cyclin D1-Cdk4 kinase activity, ONCOGENE, 19(9), 2000, pp. 1147-1152

Authors: Hofmann, TG Hehner, SP Droge, W Schmitz, ML
Citation: Tg. Hofmann et al., Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription, ONCOGENE, 19(9), 2000, pp. 1153-1163

Authors: Santos, SCR Dumon, S Mayeux, P Gisselbrecht, S Gouilleux, F
Citation: Scr. Santos et al., Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line, ONCOGENE, 19(9), 2000, pp. 1164-1172

Authors: Schuster, R Gerlich, WH Schaefer, S
Citation: R. Schuster et al., Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary ratembryo fibroblasts, ONCOGENE, 19(9), 2000, pp. 1173-1180

Authors: Belka, C Rudner, J Wesselborg, S Stepczynska, A Marini, P Lepple-Wienhues, A Faltin, H Bamberg, M Budach, W Schulze-Osthoff, K
Citation: C. Belka et al., Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis, ONCOGENE, 19(9), 2000, pp. 1181-1190

Authors: Calin, GA di Iasio, MG Caprini, E Vorechovsky, I Natali, PG Sozzi, G Croce, CM Barbanti-Brodano, G Russo, G Negrini, M
Citation: Ga. Calin et al., Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms, ONCOGENE, 19(9), 2000, pp. 1191-1195

Authors: White, JR Weston, K
Citation: Jr. White et K. Weston, Myb is required for self-renewal in a model system of early hematopoiesis, ONCOGENE, 19(9), 2000, pp. 1196-1205

Authors: North, S El-Ghissassi, F Pluquet, O Verhaegh, G Hainaut, P
Citation: S. North et al., The cytoprotective aminothiol WR1065 activates p21(waf-1) and down regulates cell cycle progression through a p53-dependent pathway, ONCOGENE, 19(9), 2000, pp. 1206-1214

Authors: Eichmann, A Yuan, L Breant, C Alitalo, K Koskinen, PJ
Citation: A. Eichmann et al., Developmental expression of Pim kinases suggests functions also outside ofthe hematopoietic system, ONCOGENE, 19(9), 2000, pp. 1215-1224

Authors: Kojima, M Morisaki, T Izuhara, K Uchiyama, A Matsunari, Y Katano, M Tanaka, M
Citation: M. Kojima et al., Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation, ONCOGENE, 19(9), 2000, pp. 1225-1231

Authors: Stroeken, PJM van Rijthoven, EAM de Boer, E Geerts, D Roos, E
Citation: Pjm. Stroeken et al., Cytoplasmic domain mutants of beta 1 integrin, expressed in beta 1-knockout lymphoma cells, have distinct effects on adhesion, invasion and metastasis, ONCOGENE, 19(9), 2000, pp. 1232-1238

Authors: Luque, I Zong, WX Chen, CL Gelinas, C
Citation: I. Luque et al., N-terminal determinants of I kappa B alpha necessary for the cytoplasmic regulation of c-Rel, ONCOGENE, 19(9), 2000, pp. 1239-1244

Authors: Hennighausen, L
Citation: L. Hennighausen, Mouse models for breast cancer, ONCOGENE, 19(8), 2000, pp. 966-967

Authors: Cardiff, RD Anver, MR Gusterson, BA Hennighausen, L Jensen, RA Merino, MJ Rehm, S Russo, J Tavassoli, FA Wakefield, LM Ward, JM Green, JE
Citation: Rd. Cardiff et al., The mammary pathology of genetically engineered mice: the consensus reportand recommendations from the Annapolis meeting, ONCOGENE, 19(8), 2000, pp. 968-988

Authors: Evans, JA Wagner, U Santos, CM Hennighausen, L
Citation: Ja. Evans et al., The interactive web-based histology atlas system, ONCOGENE, 19(8), 2000, pp. 989-991

Authors: Callahan, R Smith, GH
Citation: R. Callahan et Gh. Smith, MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways, ONCOGENE, 19(8), 2000, pp. 992-1001

Authors: Li, Y Hively, WP Varmus, HE
Citation: Y. Li et al., Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breastcancer, ONCOGENE, 19(8), 2000, pp. 1002-1009

Authors: Li, ML Lewis, B Capuco, AV Laucirica, R Furth, PA
Citation: Ml. Li et al., WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis, ONCOGENE, 19(8), 2000, pp. 1010-1019

Authors: Green, JE Shibata, MA Yoshidome, K Liu, ML Jorcyk, C Anver, MR Wigginton, J Wiltrout, R Shibata, E Kaczmarczyk, S Wang, W Liu, ZY Calvo, A Couldrey, C
Citation: Je. Green et al., The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma, ONCOGENE, 19(8), 2000, pp. 1020-1027

Authors: Schulze-Garg, C Lohler, J Gocht, A Deppert, W
Citation: C. Schulze-garg et al., A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland, ONCOGENE, 19(8), 2000, pp. 1028-1037

Authors: Dankort, DL Muller, WJ
Citation: Dl. Dankort et Wj. Muller, Signal transduction in mammary tumorigenesis: a transgenic perspective, ONCOGENE, 19(8), 2000, pp. 1038-1044

Authors: Murphy, KL Rosen, JM
Citation: Kl. Murphy et Jm. Rosen, Mutant p53 and genomic instability in a transgenic mouse model of breast cancer, ONCOGENE, 19(8), 2000, pp. 1045-1051
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>